Skip to content

Released Nov 5, 2020, before the open

10-Q filed Nov 5, 2020, 36 days after period end · 0001564590-20-050898

Q3 2020 · 10-Q
Revenue$110.99M−2.2% vs Q3 2019+51.8% vs Q2 2020
Net Income$4.65MN/M vs Q3 2019N/M vs Q2 2020
EPS Diluted$0.24N/M vs Q3 2019N/M vs Q2 2020
Gross Profit$84,742,000−4.4%
Operating Income$4,175,000N/M
Operating Cash Flowderived$21,887,000+86.3%
Free Cash Flowderived$18,822,000+147.5%
Margins · derived
Gross margin76.4%−1.7 pt vs Q3 2019
Operating margin3.8%+20.4 pt vs Q3 2019
Net margin4.2%+39.9 pt vs Q3 2019

What the release said

The release

Same quarter

MetricQ3 2020Q3 2019Q3 2018Q3 2017
Revenue$110.99M$113.50M$111.71M$105.25M
Net Income$4.65M-$40.50M-$1.21M$3.46M
EPS Diluted$0.24-$2.14-$0.07$0.19

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR